Prescription drug · ANDA
Terazosin Hydrochloride NDC 87564-082
Terazosin hydrochloride 2 mg/1 · Capsule · Oral · Amerisyn LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87564-082-01 | 8756400820187564008201 | 1000 CAPSULE in 1 BOTTLE (87564-082-01)Marketed from Aug 7, 2026 | |
| 87564-082-10 | 8756400821087564008210 | 100 CAPSULE in 1 BOTTLE (87564-082-10)Marketed from Aug 7, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terazosin Hydrochloride
- Generic name (nonproprietary)
- terazosin hydrochloride
- Active ingredients
- Terazosin hydrochloride — 2 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Amerisyn LLCNDC labeler code 87564
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074823
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 87564-082_5a95be60-b243-9183-e063-6394a90a89e6SPL ID 5a95be60-b243-9183-e063-6394a90a89e6SPL set ID 5a95be60-b242-9183-e063-6394a90a89e6RxCUI 260376, 313215, 313217, 313219UNII D32S14F082UPC 0387564082100, 0387564083015, 0387564081103, 0387564082018, 0387564081011, 0387564084012
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N487564008201followed by a unit qualifier and the quantityPackage 87564-0082-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Terazosin capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules, USP. The long-term effects of terazosin capsules, USP on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules, USP are also indicated for the treatment of hypertension. Terazosin capsules, USP can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
Excerpt only. Read the full label for complete information.
About NDC 87564-082
- What is NDC 87564-082?
- 87564-082 is the product NDC for Terazosin Hydrochloride, Terazosin hydrochloride 2 mg/1 capsule, listed with the FDA by Amerisyn LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Terazosin Hydrochloride.
- What is the active ingredient?
- Terazosin hydrochloride.
- Who is the labeler?
- Amerisyn LLC, NDC labeler code 87564. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Terazosin Hydrochloride?
- 24 other product NDCs are listed under this name. See all Terazosin Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Terazosin Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-001 | 24689-0001-0124689-0001-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-002 | 24689-0002-0124689-0002-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-003 | 24689-0003-0124689-0003-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-004 | 24689-0004-0124689-0004-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn LLC | 87564-081 | 87564-0081-0187564-0081-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn LLC | 87564-083 | 87564-0083-0187564-0083-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amerisyn LLC | 87564-084 | 87564-0084-0187564-0084-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-006 | 87564-0006-0187564-0006-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-007 | 87564-0007-0187564-0007-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-008 | 87564-0008-0187564-0008-10 |
Other NDCs under ANDA 074823
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-001 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-002 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-003 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-004 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-201 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-202 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-203 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-204 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-594 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-595 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-698 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-854 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-006 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-007 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-008 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-009 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn LLC | 87564-081 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn LLC | 87564-083 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amerisyn LLC | 87564-084 |